Cancer (Diagnostics)

GenSENSE Launched for Hereditary Cancer Risk Assessment Program

Published in Cancer Weekly, December 16th, 1996

OncorMed, Inc., Gaithersburg, Maryland, announced the launching of GenSENSE.

GenSENSE is a program designed to make advanced risk assessment tools more accessible to individual physicians and their patients at risk for developing inherited cancers. GenSENSE is comprised of three easy-to-use components to determine if a patient's family history signals an increased risk of cancer.

The confidential program begins with GenSTART, a short questionnaire designed for patients to complete in the physician's waiting room. If the brief history suggests a potential pattern of familial cancer, the physician may recommend the patient complete a more...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1996-12-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry